Nutraplus India has informed that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019, to consider and approve the un-audited financial results of the Company for the second quarter and half year ended on 30th September, 2019. Further, in terms of the Company’s Prohibition of Insider Trading Code of Conduct and provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company was closed with effect from Tuesday, 01st October, 2019 and it shall remain closed until 48 hours after the announcement of the said results. The same has been duly communicated to all the Connected and/or Designated Persons.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1520.55 |
Dr. Reddys Lab | 6217.15 |
Cipla | 1405.40 |
Zydus Lifesciences | 953.50 |
Lupin | 1589.10 |
View more.. |